Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Roche Holdings ADR RHHBY

Healthcare
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue... see more

Recent & Breaking News (OTCQX:RHHBY)

Roche Diabetes Care and mySugr expand their partnership to broaden access to digital health solutions for people with diabetes

PR Newswire Europe Non Regulatory February 15, 2017

Roche Diabetes Care Signs Exclusive Agreement with Medtronic for Bluetooth Enabled Blood Glucose Meters

PR Newswire Europe Non Regulatory February 15, 2017

Wall Street's M&A Chatter From January 31

Benzinga.com  February 1, 2017

FDA Grants Priority Review for Genentech’s Actemra® (Tocilizumab) Supplemental Biologics License Application for Giant Cell Arteritis, a Form of Vasculitis

Business Wire January 24, 2017

2 New ETFs Worth A Gander

Benzinga.com  January 20, 2017

Breakthrough development for Americans with suspected heart attack - Next generation Troponin T test from Roche cleared by FDA

PR Newswire January 19, 2017

FDA Grants Genentech’s Cancer Immunotherapy TECENTRIQ® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer

Business Wire January 9, 2017

Roche gains FDA Clearance for 18-Minute Anti-Müllerian Hormone Test to Assess Ovarian Reserve

PR Newswire January 5, 2017

FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization

Business Wire January 5, 2017

Roche launches cobas® c 513 analyzer and HbA1c Gen. 3 assay to meet increasing demand for testing of people with diabetes

PR Newswire January 4, 2017

Roche launches cobas® CT/NG on the cobas® 6800/8800 Systems in markets accepting the CE mark

PR Newswire Europe Non Regulatory December 22, 2016

Genentech’s Emicizumab for Hemophilia A Meets Primary Endpoint in Phase III Study

Business Wire December 22, 2016

Positive Phase III Results of Genentech’s Investigational Medicine OCREVUS™ (Ocrelizumab) Published in New England Journal of Medicine

Business Wire December 21, 2016

FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)

Business Wire December 20, 2016

Roche announces termination of 2013 Development, Commercialization and License Agreement with Pacific Biosciences

PR Newswire December 15, 2016

What We Know About Trump's Potential Pick To Head The FDA

Benzinga.com  December 12, 2016

FDA Approves Genentech’s Avastin® (Bevacizumab) Plus Chemotherapy for a Specific Type of Advanced Ovarian Cancer

Business Wire December 6, 2016

Good Start Genetics Announces Marketing Agreement with Roche Diagnostics for Carrier Screening in the United States

PR Newswire December 5, 2016

Genentech’s Gazyva Helped People With Previously Untreated Follicular Lymphoma Live Significantly Longer Without Their Disease Worsening Compared to Rituxan

Business Wire December 4, 2016

Roche expands distribution alliance with the life science business of Merck KGaA, Darmstadt, Germany to include Kapa Biosystems qPCR and endpoint PCR Portfolios

PR Newswire Europe Non Regulatory December 1, 2016